Research ArticleCancer

MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma

See allHide authors and affiliations

Science Translational Medicine  04 Jul 2018:
Vol. 10, Issue 448, eaan4470
DOI: 10.1126/scitranslmed.aan4470
PDF Container

Navigate This Article